NEU neuren pharmaceuticals limited

Ann: NNZ2566 Rationale in ASDs , page-2

  1. 2,802 Posts.
    lightbulb Created with Sketch. 549
    Worth a read even if you don't follow all the science (I sure don't).

    Interesting to see NEU starting to "broaden their terms of reference", so to speak, and openly discuss moving into other autism-related disorders as well as Retts. This is not "new news", so to speak, and was discussed at the AGM, but it feels to me that NEU are more openly starting to talk in terms of breadth of applications.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$16.48
Change
-0.290(1.73%)
Mkt cap ! $2.076B
Open High Low Value Volume
$16.58 $16.74 $16.40 $9.107M 549.9K

Buyers (Bids)

No. Vol. Price($)
1 864 $16.43
 

Sellers (Offers)

Price($) Vol. No.
$16.50 1668 1
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.